Fuzians Overview

  • Founded
  • 2008
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Fuzians General Information


Developer of viral entry inhibitors for the treatment of viral diseases. The company engages in the research and development of novel antiviral drugs against a number of serious viral diseases, including influenza virus, human immunodeficiency virus (HIV) and hepatitis C virus (HCV).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • Hong Kong
  • Hong Kong
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fuzians Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed
To view Fuzians’s complete valuation and funding history, request access »

Fuzians Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morningside Group Venture Capital Minority 000 0000 000000 0
To view Fuzians’s complete investors history, request access »